Mingmei Shao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine.
Journal: Frontiers in pharmacology
Published: June 17, 2022
Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism.
Journal: Frontiers in pharmacology
Published: May 17, 2022
Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3.
Journal: Frontiers in pharmacology
Published: November 29, 2021
Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: April 04, 2021
Targeted Metabolomics Identifies Differential Serum and Liver Amino Acids Biomarkers in Rats with Alcoholic Liver Disease.
Journal: Journal of nutritional science and vitaminology
Published: January 04, 2021
Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy.
Journal: Annals of translational medicine
Published: April 21, 2020
Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).
Journal: Experimental and therapeutic medicine
Published: November 26, 2019
Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases.
Journal: Journal of Cancer
Published: November 05, 2019
Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications.
Journal: Journal of Cancer
Published: November 22, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026